BCM

Bronte Capital Management Portfolio holdings

AUM $1.27B
This Quarter Return
+11.33%
1 Year Return
+15.69%
3 Year Return
+82.8%
5 Year Return
+107.03%
10 Year Return
AUM
$517M
AUM Growth
+$517M
Cap. Flow
-$74.1M
Cap. Flow %
-14.32%
Top 10 Hldgs %
96.11%
Holding
15
New
1
Increased
1
Reduced
7
Closed

Sector Composition

1 Financials 58.07%
2 Consumer Staples 20.55%
3 Materials 10.1%
4 Communication Services 8.8%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.09T
$114M 18%
491,444
-3,739
-0.8% -$867K
HLF icon
2
Herbalife
HLF
$1.01B
$99M 15.65%
2,061,245
IBKR icon
3
Interactive Brokers
IBKR
$27.7B
$78.5M 12.41%
1,289,241
-16,055
-1% -$978K
V icon
4
Visa
V
$683B
$68.3M 10.8%
312,438
-85,519
-21% -$18.7M
CTVA icon
5
Corteva
CTVA
$50.4B
$32.4M 5.11%
835,714
GOOG icon
6
Alphabet (Google) Class C
GOOG
$2.58T
$23.5M 3.71%
14,490
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$2.57T
$22M 3.48%
12,586
-34,612
-73% -$60.6M
BK icon
8
Bank of New York Mellon
BK
$74.5B
$20.4M 3.22%
480,315
-9,770
-2% -$415K
NEM icon
9
Newmont
NEM
$81.7B
$19.9M 3.14%
331,769
-49,134
-13% -$2.94M
STT icon
10
State Street
STT
$32.6B
$19.2M 3.03%
263,537
-7,489
-3% -$545K
REGN icon
11
Regeneron Pharmaceuticals
REGN
$61.5B
$9.21M 1.45%
+19,053
New +$9.21M
GHC icon
12
Graham Holdings Company
GHC
$4.74B
$7.25M 1.15%
13,588
+3,417
+34% +$1.82M
MACK
13
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.66M 0.58%
531,510
IWM icon
14
iShares Russell 2000 ETF
IWM
$67B
0
SPY icon
15
SPDR S&P 500 ETF Trust
SPY
$658B
0